Albumin Market - Top Companies and Manufacturers

Companies Dominating the Albumin Landscape

Apotex Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Octapharma AG
Bio Med International Pvt. Ltd.
Baxter
Novozymes
Mitsubishi Tanabe Pharma America Inc.
Merck KGaA
Akron Biotech
Thermo Fisher Scientific
Grifols, S.A.

Browse Key Market Insights with Data Illustration:

Albumin Market Size & Share | Growth Forecasts 2035

In the News

Apotex Corp. announced the launch of Paclitaxel, a generic version of Abrazane, it is a protein-bind particle for injection. These injections have especially been curated for the treatment of people suffering from non-small cell lung cancer, metastatic breast cancer, and adenocarcinoma of the pancreas.
Grifols, S.A. announced the launch of Albutein FlexBag in the concentration of 5% and 25%. It is available in ecologically sustainable packaging, which gives healthcare professionals a more environmentally friendly solution.

Frequently Asked Questions (FAQ)

Rising demand for immunoglobulins, higher production of new drugs, and rising cases of liver diseases and coronary issues are the major factors driving the market growth.

The market size of albumin is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are Octapharma AG, Bio Med International Pvt. Ltd., Baxter, Apotex Inc., Novozymes, Mitsubishi Tanabe Pharma America Inc., Merck KGaA, Akron Biotech, Thermo Fisher Scientific, and Grifols, S.A

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, grade, application, and by region.

The human serum albumin segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Strict rules and regulations, higher allergic reactions to albumins, and the presence of alternatives in the market are estimated to be the growth-hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Albumin Market - Top Companies and Manufacturers

Companies Dominating the Albumin Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the albumin market?

What would be the CAGR of the albumin market over the forecast period?

Who are the major players dominating the albumin market?

How are the company profiles selected?

What are the segments in the albumin market?

Which segment captures the largest market size in the type segment in the albumin market?

What are the challenges affecting the market growth?

Which region will provide more business opportunities for the growth of the albumin market in the future?